Results 1 to 10 of about 40,033 (210)
Vojnosanitetski Pregled, 2006 Background. Parathyroid carcinoma is the least frequent malignancy among endocrine tumors. In the most reported series of patients with primary hyperparathyroidism the incidence of carcinoma is less than 1%.
Filipović Aleksandar +3 more
doaj +10 more sources
British Journal of Surgery, 2005 Abstract Background Parathyroid carcinoma is a rare malignancy affecting 0·5–5 per cent of all patients with primary hyperparathyroidism. This article reviews the literature on the pathogenesis, pathology, clinical features, diagnosis and management of parathyroid carcinoma.
N, Rawat +3 more
core +8 more sources
Parathyroid carcinoma co-occurring with parathyroid adenoma and papillary thyroid carcinoma: a rare case report with comprehensive literature review [PDF]
Therapeutic Advances in Endocrinology and MetabolismParathyroid carcinoma is a rare endocrine malignancy with unclear etiology, and its clinical manifestations are often difficult to distinguish from parathyroid adenoma.
Junming Liu, Jingting Li, Yantao Fu
doaj +2 more sources
Best Practice & Research Clinical Endocrinology & Metabolism, 2018 Parathyroid carcinoma (PC) is a rare disease with an indolent behavior due to the low malignant potential. The etiology is unknown. Somatic mutations of CDC73 gene, the same gene involved in the hyperparathyroidism-jaw tumor syndrome, can be identified in up to 70% of patients with PC and in one-third of cases the mutations are germline.
Antonio Stefano, Salcuni +7 more
+9 more sources
Journal of Bone and Mineral Research, 2008 Parathyroid carcinoma is a rare endocrine tumour accounting for only about one of every hundred cases of primary hyperparathyroidism. The aetiology of this cancer remains obscure but the recent studies have identified that some gene mutations may be involved in its pathogenesis.
Marcocci, Claudio +5 more
+12 more sources
Current Treatment Options in Oncology, 2001 Although parathyroid neoplasms are common and cause primary hyperparathyroidism, parathyroid carcinoma is a rare entity. At times it can be difficult to diagnose. Patients with parathyroid carcinoma usually present with profound symptoms of hyperparathyroidism and highly elevated serum calcium and parathyroid hormone (PTH) levels.
A S, Khurana, M, Munjal, M, Narad
+9 more sources
Synchronous parathyroid carcinoma and papillary thyroid carcinoma
Clinical Case Reports, 2022 The simultaneous occurrence of parathyroid carcinoma and nonmedullary thyroid carcinoma is unusual. We report the case of 60‐year‐old woman who was found to have concurrent parathyroid carcinoma with severe clinical manifestations of primary ...
Ibtissem Ben Nacef +8 more
doaj +1 more source
Clinical Case Reports, 2023 Key Clinical Message Rare cancer originating from parathyroid parenchymal cells. Preoperative diagnosis is often difficult. Presents with normal serum levels of calcium and parathyroid hormone. Treated by en bloc resection.
Alex Mremi +4 more
doaj +1 more source
Endocrine Connections, 2023 Nineteen cases of parathyroid carcinoma in patients with multiple endocrine neoplasia type 1 have been reported in the literature, of which 11 carry an inactivating germline mutation in the MEN1 gene.
Sara Lomelino Pinheiro +5 more
doaj +1 more source
BMC Endocrine Disorders, 2021 Background Parathyroid carcinoma is a rare endocrine malignancy, rarer when synchronous with a non medullary well differentiated thyroid carcinoma. Parathyroid carcinoma accounts of 0.005% of all malignant tumors and it is responsible for less than 1% of
Nadia De Falco +11 more
doaj +1 more source